Bryan P. Schneider

Bryan P. Schneider, MD

Associate Professor of Medicine

DOWNLOAD CV

Bio

Dr. Schneider is an Associate Professor of Medicine and Medical/Molecular Genetics at the Indiana University Melvin and Bren Simon Cancer Center. Dr. Schneider devotes his clinical time caring for breast cancer patients as a Medical Oncologist. His laboratory research work is both an extension of and complimentary to his clinical interest. The research focus is on precision medicine in oncology and he has identified several markers that predict which patients might suffer severe side effects from chemotherapy drugs before they ever receive the drug. He has led several clinical trials and published over 70 original research articles in high impact medical journals and has three provisional patents for biomarkers. He is an ad hoc reviewer for multiple medical journals. His clinical and laboratory accomplishments have resulted in a multitude of invitations to advisory boards, expert panels, invited presentations, and awards; with some of those highlights as follows. He is the Vera Bradley Investigator in Breast Oncology and named to the Susan G. Komen Scientific Advisory Council; an international advisory board comprised of 50 of the most accomplished breast cancer oncologists, surgeons, and scientists across the world. His work was highlighted in the “Best of the American Society of Clinical Oncology” program as one of the most important cancer breakthroughs in 2011. In 2012 he was named to the “forty under 40” by the Indianapolis business journal; a designation as one of the most influential people in the Indianapolis metro area under 40. In 2012 he also received the Susan G. Komen for the Cure Lifetime Achievement Award. In 2014, Dr. Schneider founded and became the Director of the Indiana University Health Precision Genomics Program. This program uses cutting-edge next generation genomic sequencing of cancer patients’ tumors to uncover novel therapies for those without standard options. To date over 1000 patients across the U.S. have had their tumors sequenced in this program. This program was a Finalist for “Advancements in Health Care” by the Indianapolis Business Journal in 2016.  Based on his clinical advances and implementation in Precision Medicine, he is now a system-wide Vice President at IU Health. 

Connect


(317) 948-3855 


317-944-3646 


Hematology/Oncology
Indiana Cancer Pavilion, Suite 473 535 Barnhill Dr
Indianapolis, IN 46202-5289


  

Titles & Appointments

  • Vera Bradley Investigator in Oncology
  • Associate Professor of Medical & Molecular Genetics